Ocrelizumab
id:
ocrelizumab-161-86756
title:
Ocrelizumab
text:
Ocrelizumab, sold under the brand name Ocrevus, is a medication used for the treatment of multiple sclerosis (MS). It is a humanized anti-CD20 monoclonal antibody. It targets CD20 marker on B lymphocytes and is an immunosuppressive drug. Ocrelizumab binds to an epitope that overlaps with the epitope to which rituximab binds. It was approved by the US Food and Drug Administration (FDA) in March 2017, and the first FDA approved drug for the primary progressive form of MS; it was discovered and dev
brand slug:
wiki
category slug:
encyclopedia
description:
Anti-CD20 monoclonal antibody
original url:
https://en.wikipedia.org/wiki/Ocrelizumab
date created:
2007-01-26T23:30:21Z
date modified:
2024-08-27T01:31:17Z
main entity:
{"identifier":"Q2013780","url":"https://www.wikidata.org/entity/Q2013780"}
image:
fields total:
13
integrity:
15